STOCK-BASED COMPENSATION (Tables)
|
6 Months Ended |
Jun. 30, 2020 |
|---|
| DESCRIPTION OF BUSINESS |
|
| Schedule of Equity incentive plan |
|
|
Awards Reserved
for Issuance
|
|
|
Awards
Outstanding
|
|
|
Awards Available
for Grant
|
|
|
|
|
|
|
|
|
|
|
|
2016 Equity incentive plan |
|
|
2,000,000 |
|
|
|
544,397 |
|
|
|
1,455,603 |
|
2018 Equity incentive plan |
|
|
43,976,425 |
|
|
|
14,296,618 |
|
|
|
29,679,807 |
|
|
| Schedule of Stock based compensation assumptions |
|
|
June 30, |
|
|
June 30, |
|
|
|
2020 |
|
|
2019 |
|
Expected term (years) |
|
6 |
Years |
|
6 |
Years |
Volatility |
|
|
104.2 |
% |
|
|
115.7 |
% |
Risk-free interest rate |
|
|
0.5 |
% |
|
|
1.9 |
% |
Dividend yield |
|
|
0 |
% |
|
|
0 |
% |
|
| Schedule of Stock option activity |
|
|
Number of Shares |
|
|
Weighted-Average Exercise Price Per Share |
|
|
Weighted-Average Remaining Contractual Life |
|
Aggregate Intrinsic Value of In-the-Money Options |
|
|
|
|
|
|
|
|
|
|
Options outstanding as of January 1, 2020 |
|
|
12,365,295 |
|
|
$ |
1.24 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options granted |
|
|
9,650,000 |
|
|
$ |
0.07 |
|
|
|
|
|
|
Options exercised |
|
|
- |
|
|
$ |
- |
|
|
|
|
|
|
Options forfeited |
|
|
(6,416,667 |
) |
|
$ |
1.29 |
|
|
|
|
|
|
Options expired |
|
|
(248,048 |
) |
|
$ |
0.84 |
|
|
|
|
|
|
Options outstanding as of June 30, 2020 |
|
|
15,350,580 |
|
|
$ |
0.49 |
|
|
9.3 years |
|
$ |
.37 |
|
Options exercisable as of June 30, 2020 |
|
|
4,425,569 |
|
|
$ |
1.07 |
|
|
8.5 years |
|
$ |
- |
|
|
| Schedule of Stock-based compensation expense |
|
|
(in thousands except for shares / options) |
|
|
|
For the Three Months Ended |
|
|
|
June 30, 2020 |
|
|
June 30, 2019 |
|
Type of Award |
|
Number of Shares or Options Granted |
|
|
Stock-Based Compensation Expense |
|
|
Number of Shares or Options Granted |
|
|
Stock-Based Compensation Expense |
|
|
|
|
|
|
|
|
|
|
|
|
Stock options |
|
|
9,650,000 |
|
|
$ |
294 |
|
|
|
3,520,000 |
|
|
$ |
954 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock grants: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employees (common stock) |
|
|
826,429 |
|
|
|
57 |
|
|
|
87,798 |
|
|
|
75 |
|
Directors (common stock) |
|
|
(173,610 |
) |
|
|
(100 |
)(a) |
|
|
- |
|
|
|
- |
|
Non-employee consultants (common stock) |
|
|
250,000 |
|
|
|
33 |
|
|
|
40,000 |
|
|
|
36 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total stock-based compensation expense |
|
|
|
|
|
$ |
284 |
|
|
|
|
|
|
$ |
1,065 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Six Months Ended |
|
|
|
|
June 30, 2020 |
|
|
June 30, 2019 |
|
Type of Award |
|
Number of Shares or Options Granted |
|
|
Stock-Based Compensation Expense |
|
|
Number of Shares or
Options Granted
|
|
|
Stock-Based Compensation Expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock options |
|
|
9,650,000 |
|
|
$ |
1,238 |
|
|
|
4,000,818 |
|
|
$ |
2,236 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock grants: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employees (common stock) |
|
|
3,179,544 |
|
|
|
58 |
(b) |
|
|
473,334 |
|
|
|
390 |
|
Directors (common stock) |
|
|
(173,610 |
) |
|
|
(100 |
)(a) |
|
|
- |
|
|
|
- |
|
Non-employee consultants (common stock) |
|
|
1,075,000 |
|
|
|
48 |
|
|
|
66,376 |
|
|
|
60 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total stock-based compensation expense |
|
|
|
|
|
$ |
1,244 |
|
|
|
|
|
|
$ |
2,686 |
|
|